Description
REGISITA D Tablet is a fixed-dose combination antidiabetic medication containing sitagliptin and dapagliflozin, used for the management of type 2 diabetes mellitus. This formulation works through complementary mechanisms, promoting urinary glucose excretion and enhancing incretin hormone activity. Manufactured by a trusted pharmaceutical company, this product ensures consistent therapeutic efficacy. Take the tablet once daily as prescribed by your doctor, typically in the morning. Store in a cool, dry place, away from direct sunlight and moisture, and keep it safely out of the reach of children. Important Note: The information provided is for informational purposes only and should not be considered medical advice. Please consult your healthcare provider for proper diagnosis and treatment.
Reviews
There are no reviews yet.